Significant increase in anxiety during aging in mGlu5 receptor knockout mice

Area of Science:

• Neuroscience
• Molecular Biology
• Gerontology

Background:

• Glutamatergic signaling is crucial for neuronal circuits involved in mood and anxiety.
• Emotional disorders are challenging to treat in the elderly, with poorly understood underlying brain mechanisms.
• Metabotropic mGlu5 receptors are implicated in anxiety, as pharmacological blockade shows anxiolytic effects.

Purpose of the Study:

• To investigate the role of mGlu5 receptors in anxiety and depression during aging.
• To determine if genetic deletion of mGlu5 receptors mimics pharmacological anxiolytic effects.
• To clarify the distinct roles of mGlu5 in aging-related emotional disturbances.

Main Methods:

• Analysis of young adult and aged mice genetically modified to lack mGlu5 receptors (knockout mice).
• Behavioral assessments to evaluate anxiety-like and depressive-like phenotypes.
• Comparative analysis between young and aged mGlu5 knockout mice.

Main Results:

• mGlu5 receptor knockout mice exhibited increased anxiety, which worsened with age.
• Young adult mGlu5 knockout mice showed an anti-depressive-like phenotype.
• This anti-depressive-like effect was absent in aged mGlu5 knockout mice.

Conclusions:

• Genetic deletion of mGlu5 receptors does not produce anxiolytic effects and instead increases anxiety, particularly in aged individuals.
• mGlu5 receptors play distinct roles in modulating anxiety and depression across the lifespan, with age-dependent effects.
• These findings highlight the complex involvement of mGlu5 in aging-related emotional regulation.